Диссертация (1146685), страница 21
Текст из файла (страница 21)
Nephrol DialTransplant. – 1996. – Vol. 11. – P. 11-15.209. Levine RL. Carbonyl modified proteins in cellular regulation, aging anddisease. Free Radic Biol Med. – 2002. – Vol. 32. – P. 790-796.210. Lim PS, Lee HP, Kho B et al. Evaluation of pre- and postdilutional onlinehemodiafiltration adequate by partial dialysate quantification and online ureamonitor. Blood Purif. – 1999. – Vol. 17.
– P. 199-205.211. Lin CL, Huan CC, Yu CC, et al. Improved iron utilization and reducederythropoietin resistance by on-line hemodiafiltration. Blood Purif. – 2002. –Vol. 20. – P. 349-56.125212. Lin CL, Huang CC, Chang CT et al. Clinical improvement by increasedfrequency of on-line hemodiafiltration. Ren Fail. – 2001. – Vol. 2. – P. 193206.213. Lin CL, Huang CC, Yu CC, et al. Reduction of advanced glycation endproduct levels by on-line hemodiafiltration in long-term hemodialysis patients.Am J Kidney Dis. – 2003. – Vol. 42(3). – P. 524-31.214. Lin CL, Yang CW Chiang CC et al. Long-term on-line hemodiafiltrationreduces predialysis beta-2-microglobulin levels in chronic hemodialysispatients. Blood Purif. – 2001. – Vol. 19.
– P. 301-307.215. Locatelli F, Andrulli S, Di Filippo S et al. Effect of on-line conductivityplasma ultrafiltrate kinetic modelling on cardiovascular stability ofhemodialysis patients. Kidney Int 1998. – Vol. 53. – P. 1052-1060.216. Locatelli F, Buoncristiani U, Canaud B et al. Haemodialysis with onlinemonitoring equipment: tools or toys? Nephrol Dial Transplant. – 2005. – Vol.20. – P 22-33.217.
Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zocalli C.Oxidative stress in endstage renal disease: an emerging threat to patientoutcome. Nephrol Dial Transplant. – 2003. – Vol. 18. – P. 1272-1280.218. Locatelli F, Colzani S, D’amico M et al. Dry weight and sodium balance.Semin Nephrol.
– 2001. – Vol. 21. – P. 291-297.219. Locatelli F, Del Vecchio L, Andrulli S. Dialysis: its role in optimizingrecombinant erythropoietin treatment. Nephrol Dial Transplant. – 2001. – Vol.16. – P. 29-35.220. Locatelli F, Del Vecchio L, Andrulli S. The modality of dialysis treatment:does it influence the response to erythropoietin treatment? Nephrol DialTransplant. – 2001. – Vol. 16. – P. 1971-1974.221.
Locatelli F, Di Filippo S, Pozzoni P. A Critical Assessment of UremiaResearch. Blood Purif. – 2006. – Vol. 24. – P. 71 – 76.126222. Locatelli F, Manzoni C. Treatment modalities in comparison: when doclinical differences emerge? Nephrol Dial Transplant. – 2000. – Vol. 15. – P.29-35.223. Locatelli F, Marcelli D, Conte F, et al. Comparison of mortality in ESRDpatients on convective and diffusive extracorporeal treatments. The RegistroLombardo Dialisi E Trapianto. Kidney Int. – 1999. – Vol. 55(1) .
– P. 286-93.224. LondonGM.Cardiovasculardiseaseinchronicrenalfailure:pathophysiologic aspects. Seminars in Dialysis. – 2003. – Vol. 16 (2) . – P. 8594.225. Lüscher, T. The endothelium and cardiovascular disease – a complexrelation. NEJM. – 2012. – Vol. 330 (15). – P. 1081-1083.226. Madore F. Uremia-related metabolic cardiac risk factors in chronic kidneydisease. Seminars in Dialysis.
– 2003. – Vol. 16 (2) . – P. 148-156.227. Maduell F, del Pozo C, Garcia H et al. Change from conventionalhaemodiafiltration to online haemodiafiltration. Nephrol Dial Transplant. –1999. – Vol. 14. – P. 1202-1207.228. Maduell F, Navarro V, Rius A et al. Improvement of nutritional status inpatients with short daily on-line hemodiafiltration.
Nefrologia. – 2004. – Vol.24. – P. 60-66.229. Maduell R, Navarro V, Torrebrosa E et al. Change from three times a weekon-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int. –2003. – Vol. 64. – P. 305-313.230. Maggiore Q, Pizzarelli F, Dattolo P et al. Cardiovascular stability duringhaemodialysis,haemofiltrationandhaemodiafiltration.NephrolDialTransplant.
– 2000. – Vol. 15. – P. 68-73.231. Maggiore Q, Pizzarelli F, Santoro A et al. The effect of control of thermalbalance on vascular stability in hemodialysis patients: results of the Europeanrandomized clinical trial. Am J Kidney Dis. – 2002. – Vol. 40(2) . – P. 280290.127232. Mahoney F. Functional evaluation: the Barhtel Index / F. Mahoney, D.Bartel // MD State Med. J. – 1965. – Vol. 14. – P. 61–65.233.
Mallamaci F, Scudo P, Tripepi G et al. Hyperhomocysteinemia as a riskfactor for AV-fistula thrombosis. J Nephrol. – 2002. – Vol. 15. – P. 733.234. Malyszko JS, Malyszko J, Hryszko T et al. Markers of endothelial damagein patients on haemodialysis and haemodiafiltration. J Nephrol. – 2006. – Vol.19. – P.
150-154.235. Man NK. Controversies and Issues in Hemodiafiltration Therapy. BloodPurif. – 2004. – Vol. 22. – P. 2-7.236. Mauri. M. Effects of psychopathological components of the onset ofAlzheimer’s disease / M. Mauri, S. Bravin, L. Fabiano, G. Invernizzi //Minerva Psychiatrica. – 1995. – Vol.
36. – № 4. – P. 200–207.237. Mawar S, Gupta S, Mahajan S. Non-compliance to the continuousambulatory peritoneal dialysis procedure increases the risk of peritonitis. IntUrol Nephrol. – 2012 Aug. – Vol. 44(4). – P. 1243-9238. McKane W, Chandna SM, Tattersall JE, et al. Identical decline of residualrenal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int.– 2002. – Vol. 61. – P. 256-65.239. Merkus MP., Jager KJ., Dekker FW., Boeschoten EW., Stevens P., KredietRT Quality of life in patients on chronic dialysis: self-assessment 3 monthsafter the start of treatment.
Am J Kidney Dis. – 1997 Apr. – Vol. 29(4) . – P.584-92.240. Meyer TW, Walther JL, Pagtalunan ME et al. The clearance of proteinboundsolutes by hemofiltration and hemodiafiltration. Kidney Int. – 2005. – Vol. 68pp. 867 – 877.241. Morena M, Cristol JP, Bosc JC et al. Convective and diffusive losses ofvitamin C during haemodiafiltration session: a contributive factor to oxidativestress in haemodialysis patients.
Nephrol Dial Transplant. – 2002. – Vol. 17. –P. 422-427.128242. Munoz R, Gallardo I, Valladares E et al. Online hemodiafiltration: 4 years ofclinical experience. Hemodialysis International. – 2006. – Vol. 10. – P. S28S32.243. Nakai S, Iseki K, Tabei K et al. Outcomes of hemodiafiltration based onJapanese dialysis patient registry. Am J Kidney Dis. – 2001. – Vol. 38. – P.212-216.244. Navino C, Tetta C, Tessore V et al.
Assessment of efficiency using onlineurea kinetic modelling in hemodiafiltration. ASAIO. – 1998. – Vol. 44. – P.565-568.245. Niwa T. Dialysis-related amyloidosis: pathogenesis focusing on AGEmodification. Semin Dial. – 2001. – Vol. 14. – P. 123-126.246. Oyekçin DG, Gülpek D, Sahin EM, Mete L. Depression, anxiety, bodyimage, sexual functioning, and dyadic adjustment associated with dialysis typein chronic renal failure. Int J Psychiatry Med. – 2012. – Vol.
43(3). – P. 22741.247. Ozkahya M, Toz H, Unsal A et al. Treatment of hypertension in dialysispatients by ultrafiltration: role of cardiac dilatation and time factor. Am JKidney Dis. – 1999. – Vol. 34. – P. 218-221.248. Pak R. Stroke / R. Pak, M.L. Dombovy // Handbook of Neurorehabilitation /ed. by D.C. Good, J.R. Couch.
– New York: Marcel Dekker, Inc., 1994. – P.461–491.249. Pang SK., Ip WY., Chang AM. Psychosocial correlates of fluid complianceamong Chinese haemodialysis patients. J Adv Nurs. – 2001 Sep. – Vol. 35(5).– P. 691-8.250. Panichi V, De Pietro S, Andreini B et al. Cytokine production inhaemodiafiltration: a multicentre study. Nephrol Dial Transplant. – 1998. –Vol. 13. – P. 1737-1744.251. Panichi V, Migliori M, De Pietro S et al. C-reactive protein as a marker ofchronic inflammation in uremic patients. Blood Purif. – 2000.
– Vol. 18. – P.183-190.129252. Kellum JA, Johnson JP, Kramer D et al. Diffusive vs. Convective therapy:effects on mediators of inflammation patients with severe systemicinflammatory response syndrome. Crit Care Med. – 1998. – Vol. 26. – P. 19952000.253.
Panichi V, Migliori M, De Pietro S et al. Plasma C-reactive protein inhemodialysis patients: a cross sectional, longitudinal clinical survey. BloodPurif . – 2000. – Vol. 18. – P. 30-36.254. Patrick DL., Erickson P. Health related status and Health Policy. AllocatingResources to Health Care.